VADUZ, Liechtenstein and MUNICH, July 17, 2014 /PRNewswire/ — The QUANT e-Sportlimousine with nanoFLOWCELL® drivetrain concept has been approved by TUV Sud in Munich for use on public roads. Nunzio La Vecchia, chief technical officer at nanoFLOWCE…
HONG KONG, July 17, 2014 /PRNewswire/ — Brandma.Co Limited, the leading brand management and protection expert in China, announced on July 16, 2014 that Mr. Seinosuke Sato has made an early-stage strategic investment to the company. The deal was completed last week in Hong Kong with the terms undisclosed.
Mr. Sato is a renowned entrepreneur and investor in Silicon Valley and Tokyo. His most recent venture is BrainPad Inc., an industry pioneer in the Big Data field, which offers cutting-edge analytical services and solutions to large-scale web portals, as well as serving retail, finance, telecom, and e-commerce enterprises in Japan. “I firmly believe Brandma has already seized the window of opportunity in the China market,” said Mr. Sato. “The team has demonstrated terrific power of execution and is fulfilling the demanding needs for brand protection in China. I will assist Brandma by enhancing its data processing and analytics capability, upgrading its online brand monitoring and fraud detection mechanism, as well as accelerating Brandma’s global expansion strategy.”
“It’s our honor to earn distinguished investors like Sato-san’s recognition of Brandma’s value and share our vision,” said Mr. Ching Chiao, Founder and the CEO of Brandma.Co. “With Sato-san’s guidance and experience, Brandma is advancing to become a world-class technology company. Our existing customers and partners can rest assured that Brandma continues to offer a reliable, scalable and secure platform for protecting their domain names, trademarks, as well as other digital brand assets. Most importantly, we will keep acting proactively and aggressively in acquiring customers to sustain our market leader position in this competitive market.”
Mr. Chiao also serves as an ICANN GNSO Councilor who oversees the global top-level domain name policies, and a Board Member of .asia TLD registry. He founded Brandma.Co Limited in early 2013 and the company has operations in Beijing, Chengdu, Hong Kong, and Taipei.
Ms. Cathy Peng
BEIJING, July 7, 2014 /PRNewswire/ — During German Chancellor Dr Angela Merkel’s state visit to China, Song Zhiyong, President & Executive Director of Air China Limited and Carsten Spohr, Chairman of the Executive Board and CEO…
CLEVELAND, July 17, 2014 /PRNewswire/ — Medical simulation technology provides an excellent approach to training physicians, nurses and allied health personnel. However, medical simulation development and utilization does not have to stop with training. Simbionix USA Corporation advances the concept of using its proprietary technologies and capabilities to turn the simulation experience into an essential part of pre-operative surgery planning.
The company’s revolutionary PROcedure Rehearsal Studio™ (PRS) steps up simulation by enabling physicians to rehearse a complete endovascular procedure on a virtual 3D anatomical model based on a specific patient’s CT data. The virtual model can be used for simulating, analyzing and evaluating pre-operative surgical treatment options prior to performing an actual case, which may increase a physician’s confidence in the upcoming procedure.
The advantages of patient specific planning have long been recognized in other fields within the healthcare industry, such as medical imaging. Simbionix is pleased to announce the signing of a collaboration agreement with the market leader in medical image analysis software, Pie Medical Imaging BV. The company manufactures and distributes the 3mensio software, a clinical application that enables the visualization and analysis of patient CT scans in both 2D and 3D modes.
The collaboration will enable exporting the 3mensio Vascular™ model into the Simbionix simulation environment to form a comprehensive planning solution that combines 3DR, data analysis and simulation on the same platform. The solution will allow physicians and clinical specialists to rehearse a procedure in a complete virtual environment without the need for physical tools. This will take users of the 3mensio software to the next level of preparedness for endovascular procedures, as it will allow added simulation insights. Cases created by the software may also be imported to the ANGIO Mentor simulator for full procedure practice using fluoroscopy, guidewires, catheters, and other equipment that is used in the cath lab.
Simbionix recently received the CE marking of conformity for its patient specific simulation, an important step towards launching this innovative technology and expansion of its use in the clinical practice. The PRS CE mark demonstrates the product’s compliance with stringent requirements related to the quality, safety, and performance of medical devices determined by the European Union legislation.
In addition, Simbionix PRS has recently been granted a patent in China. The company now has patents for this technology in three key countries: the USA, UK and China. These patents represent recognition for Simbionix’s comprehensive line of products, which provide innovative solutions to advance medical performance and ensure patient safety.
Gary Zamler, Simbionix CEO added that “Growing interest from the image analysis market, which 3mensio is part of, demonstrates the need for more comprehensive planning solutions. The ability to evaluate surgical treatment options using simulation anytime, anywhere, is a major factor in achieving the goal to increase patient safety and improve procedure outcomes. The collaboration agreement, CE mark and additional patent are all examples of the company’s key position as a market leader and innovator in the field of medical simulation.”
Contact: Rebecca Levy, Rebecca@simbionix.com, +1-216-2292040
SINGAPORE, July 17, 2014 /PRNewswire/ — Max Bupa Health Insurance has been recognized as the Celent Model Insurer of Asia for 2014, one of the most coveted honour in APAC region, for effective technology usage in insurance. With a strong focus on utilizing technology to deliver the best in class service, Max Bupa is creating a benchmark in the industry through innovative IT practices. Max Bupa’s focus from the time of inception has been to evolve and transform customer experience, by offering exceptional customer service through smart and hassle free processes.
Max Bupa implemented Newgen Software Technologies’ BPM solution to automate core processes like New Business, Claims, Healthcare Provider Enrolment, Agent Licensing, and Renewals. These solutions together enhanced customer experience through improved interactions, and reduced customer response timelines. Newgen’s mobility application ZapIn enabled end to end automation of the highly critical New Business process thus providing a uniform end user experience. Through this implementation, Max Bupa became the first insurer in India to introduce a mobility application into its customer acquisition process.
Commenting on the win, Somesh Chandra, Director – Customer Service, Operations and Technology, Max Bupa said, “It is an honour to be recognized for our technological prowess by Celent. At Max Bupa, we have a strong focus on utilizing technology to deliver the best in class service and a seamless experience to our customers, partners and employees. We have a clear roadmap to ensure our technology implementation maintains a competitive edge and addresses evolving customer needs. The innovative IT solutions by Newgen have helped us streamline and automate our customer facing business processes.”
Puneet Nath Kapil, Vice-President (IT), Max Bupa added, “We needed a solution to bring about overall improvement in terms of process efficiency, SLA adherence and customer engagements. Newgen with its vast domain expertise, robust product platforms and invigorating business solutions helped us significantly improve our customer response rate.”
Diwakar Nigam, MD & CEO, Newgen Software said, “Every implementation we undertake comes with a unique set of challenges. We have, over the years strived to find invigorating solutions to these challenges. Max Bupa’s win is a testimonial of our success.”
Celent is a leading research and consulting firm focused on the application of information technology in the global financial services industry. Max Bupa won this honour amongst the 18 other insurers.
Media contact: Asif Khan, +65-6221-8432, Asif.firstname.lastname@example.org
SINGAPORE, July 17, 2014 /PRNewswire/ —
Cloud-Based Integrated Marketing Platform Leader Expands Presence and Partner Ecosystem to Help Retailers Drive Sales through Capillary Intelligent Customer Engagement™ Suite
Capillary Technologies, the market leader in cloud-based retail customer engagement management, today announced that it has closed a $14 million Series B round of venture financing. This new investment adds to the $17 million of Series A funding received in 2012, providing a sizable balance to fund continued growth. Sequoia Capital and Norwest Venture Partners (NVP) led this round. The funding will be used to enhance Capillary’s cloud-based integrated marketing platform and grow its partnership ecosystem, which already includes Blue Label Engage in South Africa and the American Express US Global Merchants Services group.
“Continued funding by both Sequoia and NVP is a vote of confidence in our vision and continued traction in the marketplace. By harnessing the power of Capillary’s Intelligent Customer Engagement™ Suite, retailer marketers are forming successful and personalized relationships with their customers based on insights from our customer analytics platform across multiple channels,” said Aneesh Reddy, co-founder and CEO of Capillary Technologies. “Retailers realize a 15% increase in Average Basket Value and 30% increase in their customer retention rate by implementing our solutions, which is the reason we continue to grow so rapidly around the world.”
Capillary’s insights-driven, integrated marketing platform helps retailers to quickly and easily manage their customer data, gain insights and personalize engagement across multiple channels, driving a significant increase in sales and loyalty. Capillary’s Intelligent Customer Engagement™ (ICE) suite of software solutions incorporates everything that retail marketers require to engage with their customers, weaving social and mobile experiences into any e-commerce platform or point-of-sale device from legacy terminals to the latest POS devices, mobile tablets, and online shopping platforms.
With the announcement of funding also comes the announcement of a new partner, Agilysys. Agilysys is a leading developer and marketer of proprietary enterprise software, services and solutions to the hospitality industry and operates extensively throughout North America, Europe and Asia. “We are excited to have them on board and our partnership will allow us to bring innovative solutions to companies of all sizes in the hospitality industry,” said Anant Choubey, Vice President of the APAC region at Capillary Technologies.
Notable new customers include Marks & Spencer, a leading apparel retailer with stores in Europe, Middle East and Asia, KFC, the world’s most popular chicken restaurant chain, Lacoste, a leading French bridge-to-luxury brand, Keedo, a leading children’s clothing manufacturers in South Africa, and Courts, one of the top electrical, IT and furniture retailers in Southeast Asia.”
“We want to continue to provide innovative shopping experiences for our customers. Capillary’s insights-driven approach has allowed us to more precisely target prospects in six European countries who will be most receptive to our expanded product line,” said Zdenek Hasek, Head of Marketing at Marks & Spencer for Czech Republic, Poland, Slovakia and Baltics.
As evidence of its continued success, Capillary and its Customer Engagement Management platform has been honored with awards such as one of the 20 Most Promising Digital Marketing Solutions by CIO Review Magazine, Always On Global 250 Top Private Companies, Winner of Top 50 Startups by TiE Silicon Valley, Innovative 100 by Inc. Magazine’s India, and CIO Asia‘s 20 Most Promising Product Companies.
Contact Capillary Technologies:
Director of Marketing, AP and MEA
SHANGHAI, July 17, 2014 /PRNewswire/ — Following the huge success of MEDTEC China on-site conference 2012 & 2013, MDiT Forum and Regulation Summit 2014 will continue to focus on regulatory updates & market access, product design & manufacture and risk management & quality control of medical devices. The conference will be held on September 25th-26th at Shanghai World Expo Exhibition & Convention Center and will keep using the theme of “Gearing up MD Development by Regulations & Innovations” which was very well-received by attendees in 2013. The conference will aim to provide you with the latest regulatory updates and advanced technology sharing.
- Covering hot topics of updates on Chinese/overseas regulation, new technology, new material application and quality control of medical device
- Resource integration and sharing of MEDTEC Global, 23+ international high-quality speakers
- Exploring advanced technique and market information and to acquire development opportunities
- MEDTEC Investment Summit takes place during MEDTEC, looking for capital opportunity for product and in-depth business cooperation
- 5 theme modules, MEDTEC exhibition and conference, showcase and presentation promoted simultaneously
Call for Speakers
UBM/MEDTEC is compiling a great roster of thought leaders and industry insiders for a program packed with timely insights, strategic views, and actionable items. If you would like to have the opportunity to speak at MEDTEC on-site conference 2014, please submit your proposed topic, biography and contact information to us.
Ms. Jessie Jiang
email@example.com / +86 21 6157 3933
Sponsorship & Delegates:
Ms. Julia Zhu
Julia.firstname.lastname@example.org / +86 21 6157 3922
Ms. Heron Zhuang
Heron.email@example.com / +86 21 6157 3928
Media & PR:
Ms. Alisha Zhou
Alisha.firstname.lastname@example.org /+86 21 6157 3930